| dc.contributor.author | Kirovski, Marko | |
| dc.contributor.author | Paušak, Ljiljana | |
| dc.contributor.author | Lazić, Sava | |
| dc.date.accessioned | 2019-11-01T10:28:43Z | |
| dc.date.available | 2019-11-01T10:28:43Z | |
| dc.date.issued | 2019-04 | |
| dc.identifier.isbn | 978-86-83115-36-5 | |
| dc.identifier.uri | https://repo.niv.ns.ac.rs/xmlui/handle/123456789/89 | |
| dc.publisher | SVD, Sekcija za zoonoze, Beograd | en_US |
| dc.source | Zbornik kratkih sadržaja, XXI Simpozijum epizootiologa i epidemiologa (XXI Epizootiološki dani), Novi Sad, 8-10. april 2019 | sr |
| dc.subject.classification | pigs | En |
| dc.subject.classification | vaccine | En |
| dc.subject.classification | Aujeszky`s disease | En |
| dc.title | Production and characteristics of vaccine against Aujeszky's disease produced by Veterinary Institute Subotica | en_US |
| dc.title.alternative | Proizvodnja i karakteristike vakcine protiv Aujeskijeve bolesti proizvođača Veterinarski zavod Subotica | en_US |
| dc.title.alternative | | en_US |
| dc.type | Other | en_US |
| dcterms.abstract | Aujeszky`s disease (Morbus Aujeszky) is acute viral contagious disease of many
domestic and wild animal species. Disease is common in swine. It may lead to massive
death of piglets, abortion, fetal mummification and birth of poor vital piglets. In
fattening pigs, disease may cause respiratory disturbances, growth retardation, and
death occasionally. Causer belongs to family Herpesviridae, subfamily
Аlphaherpesvirinae, genus Varicellovirus. Vaccine against Aujeszky`s disease is used
for active immunization of pigs against causer of disease, with a final goal to prevent
mortality and clinical signs. Vaccine contains live attenuated Aujeszky`s disease virus
(strain Bartha) and is used for active immunization of healthy pigs and piglets. Piglets
that originated from immunized mothers should be vaccinated seven days before
weaning and those that originated from non-immunised mothers should be vaccinated
at least at 14 days of age. Piglets are revaccinated at the age of three to four months.
Immunity occurs 14 days later and protection lasts a year after revaccination. | En |
